Nuclear receptor mRNA expression by HBV in human hepatoblastoma cell lines

Cancer Letters

Volumn 312, Issue 1, 2011, Pages 33-42

  Wu, Shuang ^a   Kanda, Tatsuo ^a   Imazeki, Fumio ^a   Nakamoto, Shingo ^a   Shirasawa, Hiroshi ^a   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

HBV; HCC; HDAC; Hepatocarcinogenesis; Nuclear receptor

Indexed keywords

CELL NUCLEUS RECEPTOR; COMPLEMENTARY DNA; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; HEPATITIS B VIRUS; HEPATOBLASTOMA; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; VIRION; VIRUS REPLICATION;

CELL LINE, TUMOR; CELL SURVIVAL; CELL TRANSFORMATION, VIRAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HEP G2 CELLS; HEPATITIS B VIRUS; HEPATOBLASTOMA; HUMANS; LIVER NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 80053303827     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.07.025     Document Type: Article

References (46)

1. Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin. Liver Dis. 2010, 30:303-316.
2. Bosch F.X., Ribes J., Diaz M., Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004, 127:S5-S16.
3. Koike K. Hepatitis B virus X gene is implicated in liver carcinogenesis. Cancer Lett. 2009, 286:60-68.
4. Patient R., Hourioux C., Roingeard P. Morphogenesis of hepatitis B virus and its subviral envelope particles. Cell Microbiol. 2009, 11:1561-1570.
5. Di Bisceglie A.M. Hepatitis B and hepatocellular carcinoma. Hepatology 2009, 49:S56-S60.
6. Lok A.S., McMahon B.J. Chronic hepatitis B. Hepatology 2007, 45:507-539.
7. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
8. Aranda A., Pascual A. Nuclear hormone receptors and gene expression. Physiol. Rev. 2001, 81:1269-1304.
9. Chiu C.M., Yeh S.H., Chen P.J., Kuo T.J., Chang C.J., Yang W.J., Chen D.S. Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level. Proc. Natl. Acad. Sci. USA 2007, 104:2571-2578.
10. Kanda T., Steele R., Ray R., Ray R.B. Hepatitis C virus core protein augments androgen receptor-mediated signaling. J. Virol. 2008, 82:11066-11072.
11. Naugler W.E., Sakurai T., Kim S., Maeda S., Kim K., Elsharkawy A.M., Karin M. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 2007, 317:121-124.
12. Reese V., Ondracek C., Rushing C., Li L., Oropeza C.E., McLachlan A. Multiple nuclear receptors may regulate hepatitis B virus biosynthesis during development. Int. J. Biochem. Cell Biol. 2011, 43:230-237.
13. Dauphinee M.J., Mizejewski G.J. Human alpha-fetoprotein contains potential heterodimerization motifs capable of interaction with nuclear receptors and transcription/growth factors. Med. Hypotheses 2002, 58:453-461.
14. Wakui Y., Inoue J., Ueno Y., Fukushima K., Kondo Y., Kakazu E., Obara N., Kimura O., Shimosegawa T. Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone. Biochem. Biophys. Res. Commun. 2010, 396:508-514.
15. Acs G., Sells M.A., Purcell R.H., Price P., Engle R., Shapiro M., Popper H. Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc. Natl. Acad. Sci. USA 1987, 84:4641-4644.
16. Sells M.A., Chen M.L., Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 1987, 84:1005-1009.
17. Sells M.A., Zelent A.Z., Shvartsman M., Acs G. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J. Virol. 1988, 62:2836-2844.
18. Wu S., Kanda T., Imazeki F., Arai M., Yonemitsu Y., Nakamoto S., Fujiwara K., Fukai K., Nomura F., Yokosuka O. Hepatitis B virus e antigen downregulates cytokine production in human hepatoma cell lines. Viral. Immunol. 2010, 23:467-476.
19. Okitsu K., Kanda T., Imazeki F., Yonemitsu Y., Ray R.B., Chang C., Yokosuka O. Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer. Genes Cancer 2010, 1:859-867.
20. Wang S., Tang H., He F., Liu L., Huang F.J., Zhou T.Y., Zhao L.S. On the role of liver-enriched transcription factors in regulating HBV transcription and replication. Sichuan Da Xue Xue Bao Yi Xue Ban 2006, 37:35-39.
21. Gilbert S., Galarneau L., Lamontagne A., Roy S., Belanger L. The hepatitis B virus core promoter is strongly activated by the liver nuclear receptor fetoprotein transcription factor or by ectopically expressed steroidogenic factor 1. J. Virol. 2000, 74:5032-5039.
22. Ding X.R., Yang J., Sun D.C., Lou S.K., Wang S.Q. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs. Pharmacogenomics J. 2008, 8:61-70.
23. Yu X., Mertz J.E. Distinct modes of regulation of transcription of hepatitis B virus by the nuclear receptors HNF4alpha and COUP-TF1. J. Virol. 2003, 77:2489-2499.
24. Wu L.M., Yang Z., Zhou L., Zhang F., Xie H.Y., Feng X.W., Wu J., Zheng S.S. Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma. PLoS One 2010, 5:e14460.
25. Walton T.J., Li G., Seth R., McArdle S.E., Bishop M.C., Rees R.C. DNA demethylation and histone deacethylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines. Prostate 2008, 68:2010-2022.
26. Tur-Kaspa R., Shaul Y., Moore D.D., Burk R.D., Okret S., Poellinger L., Shafritz D.A. The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virology 1988, 167:630-633.
27. Guidotti L.G., Eggers C.M., Raney A.K., Chi S.Y., Peters J.M., Gonzalez F.J., McLachlan A. In vivo regulation of hepatitis B virus replication by peroxisome proliferators. J. Virol. 1999, 73:10377-10386.
28. Garcia A.D., Ostapchuk P., Hearing P. Functional interaction of nuclear factors EF-C, HNF-4, and RXR alpha with hepatitis B virus enhancer. J. Virol. 1993, 67:3940-3950.
29. Huan B., Siddiqui A. Retinoid X receptor RXR alpha binds to and trans-activates the hepatitis B virus enhancer. Proc. Natl. Acad. Sci. USA 1992, 89:9059-9063.
30. Yu X., Mertz J.E. Critical roles of nuclear receptor response elements in replication of hepatitis B virus. J. Virol. 2001, 75:11354-11364.
31. Wang S.H., Yeh S.H., Lin W.H., Wang H.Y., Chen D.S., Chen P.J. Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology 2009, 50:1392-1402.
32. Wu M.H., Ma W.L., Hsu C.L., Chen Y.L., Ou J.H., Ryan C.K., Hung Y.C., Yeh S., Chang C. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Sci. Transl. Med. 2010, 2:32ra35.
33. Almog Y., Klein A., Adler R., Laub O., Tur-Kaspa R. Estrogen suppresses hepatitis B virus expression in male athymic mice transplanted with HBV transfected Hep G-2 cells. Antiviral Res. 1992, 19:285-293.
34. Han J., Ding L., Yuan B., Yang X., Wang X., Li J., Lu Q., Huang C., Ye Q. Hepatitis B virus X protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cells. Nucleic Acids Res. 2006, 34:3095-3106.
35. Chung Y.L., Tsai T.Y. Promyelocytic leukemia nuclear bodies link the DNA damage repair pathway with hepatitis B virus replication: implications for hepatitis B virus exacerbation during chemotherapy and radiotherapy. Mol. Cancer Res. 2009, 7:1672-1685.
36. Sorin M., Cano J., Das S., Mathew S., Wu X., Davies K.P., Shi X., Cheng S.W., Ott D., Kalpana G.V. Recruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replication. PLoS Pathog. 2009, 5:e1000463.
37. Walters M.S., Erazo A., Kinchington P.R., Silverstein S. Histone deacetylases 1 and 2 are phosphorylated at novel sites during varicella-zoster virus infection. J. Virol. 2009, 83:11502-11513.
38. Katsura T., Iwai S., Ota Y., Shimizu H., Ikuta K., Yura Y. The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells. Cancer Gene Ther. 2009, 16:237-245.
39. Luczak M.W., Jagodzinski P.P. Apicidin down-regulates human papillomavirus type 16 E6 and E7 transcripts and proteins in SiHa cervical cancer cells. Cancer Lett. 2008, 272:53-60.
40. Balakrishnan L., Milavetz B. HDAC inhibitors stimulate viral transcription by multiple mechanisms. Virol J. 2008, 5:43.
41. Popov V.M., Wang C., Shirley L.A., Rosenberg A., Li S., Nevalainen M., Fu M., Pestell R.G. The functional significance of nuclear receptor acetylation. Steroids 2007, 72:221-230.
42. Fu M., Rao M., Wu K., Wang C., Zhang X., Hessien M., Yeung Y.G., Gioeli D., Weber M.J., Pestell R.G. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. J. Biol. Chem. 2004, 279:29436-29449.
43. Mactavish H., Diallo J.S., Huang B., Stanford M., Le Boeuf F., De Silva N., Cox J., Simmons J.G., Guimond T., Falls T., McCart J.A., Atkins H., Breitbach C., Kirn D., Thorne S., Bell J.C. Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors. PLoS One 2010, 5:e14462.
44. Archin N.M., Keedy K.S., Espeseth A., Dang H., Hazuda D.J., Margolis D.M. Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors. AIDS 2009, 23:1799-1806.
45. Watanabe T., Hioki M., Fujiwara T., Nishizaki M., Kagawa S., Taki M., Kishimoto H., Endo Y., Urata Y., Tanaka N. Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells. Exp. Cell Res. 2006, 312:256-265.
46. Trauner M., Halilbasic E. Nuclear receptors as new perspective for the management of liver diseases. Gastroenterology 2011, 140:1120-1125.